World’s first international pharmaceutical seminar on Transmission Raman Spectroscopy
Posted: 31 July 2015 |
Cobalt is hosting the first ever seminar on the use of Transmission Raman Spectroscopy (TRS) in quantitative pharmaceutical analysis…
Cobalt is hosting the first ever seminar on the use of Transmission Raman Spectroscopy (TRS) in quantitative pharmaceutical analysis. The seminar will take place at the University of Oxford on December 3rd 2015 and features presentations from experienced transmission Raman users at Actavis, Bristol-Myers Squibb, Janssen, GSK and AbbVie, with a regulatory perspective presented by the UK’s Medical and Healthcare products Regulatory Agency (MHRA). Actavis will give the keynote lecture on how they obtained regulatory approval for content uniformity methods using TRS.
Transmission Raman spectroscopy (TRS) is an alternative to HPLC for tablet & capsule content uniformity testing and an alternative to ssNMR and XRPD for high-speed, low detection limit polymorph quantification. Pharmaceutical manufacturers are increasingly using Cobalt’s TRS100 system in R&D and production environments because of the benefits it offers: TRS takes seconds per sample, is robust to sample variation, needs no preparation, solvents or consumables and saves significant cost and resource per batch.
For full seminar details and to register, visit www.cobaltlight.com/trs100seminar
This seminar announcement comes as part of a series of recent news and publications featuring TRS and Cobalt’s TRS100 system:
- The July edition of European Pharmaceutical Review features an article from Actavis UK describing their regulatory approval process for content uniformity testing using transmission Raman spectroscopy and the TRS100 – read more
- A new Cobalt paper published in the Journal of Pharmaceutical and Biomedical Analysis describes – for the first time – comprehensive quantification of tablets with multiple active pharmaceutical ingredients using transmission Raman spectroscopy – read more
- In March 2015 Cobalt was awarded a Horizon 2020 grant from the European Union to investigate high-speed online pharmaceutical analysis using transmission Raman spectroscopy – read more
For more information: